To include your compound in the COVID-19 Resource Center, submit it here.

Teva sales and marketing update

Teva launched a generic version of 0.5 and 1 mg Baraclude entecavir in the U.S.

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE